Benefits and Risks of Statin Therapy in the HIV-Infected Population
Author:
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases
Link
http://link.springer.com/article/10.1007/s11908-018-0628-7/fulltext.html
Reference91 articles.
1. Endo A. The discovery and development of HMG-CoA reductase inhibitors. J Lipid Res. 1992;33(11):1569–82.
2. Sirtori CR. The pharmacology of statins. Pharmacol Res. 2014;88:3–11.
3. Brunengraber H. New mechanisms by which statins lower plasma cholesterol. J Lipid Res. 2016;57(8):1325–6.
4. Schonewille M, Freark de Boer J, Mele L, Wolters H, Bloks VW, Wolters JC, et al. Statins increase hepatic cholesterol synthesis and stimulate fecal cholesterol elimination in mice. J Lipid Res. 2016;57(8):1455–64.
5. •• Gili S, et al. Comparative safety and efficacy of statins for primary prevention in human immunodeficiency virus-positive patients: a systematic review and meta-analysis. Eur Heart J. 2016;37(48):3600–9. This is a recent meta-analysis of all research on statin use in HIV-positive patients on combination anti-retroviral therapy (cART). This meta-analysis not only demonstares efficacy of statins in HIV-infected patients receiving ART but also demontrates a good safety profile
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Statin use for cardiovascular disease prevention: perceptions among people living with HIV in the United States;BMC Primary Care;2024-04-17
2. Pitavastatin in the Prevention of Cardiovascular Disease in People Living with HIV: A Review;Cardiology in Review;2024-01-31
3. Evaluating the use of antiviral drugs in HIV patients with cardiovascular diseases and how to reduce the incidence of cardiac events in these patients;American Journal of Cardiovascular Disease;2024
4. Current Scenario and Strategies to Tackle Cardiovascular Disease Risk in HIV Geriatrics;Current Pharmacology Reports;2023-09-05
5. Pneumolysin as a target for new therapies against pneumococcal infections: A systematic review;PLOS ONE;2023-03-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3